| 发明名称 |
TACI-IMMUNOGLOBULIN FUSION PROTEINS |
| 摘要 |
<p>Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.</p> |
| 申请公布号 |
EP1436003(A2) |
申请公布日期 |
2004.07.14 |
| 申请号 |
EP20020734478 |
申请日期 |
2002.05.20 |
| 申请人 |
ZYMOGENETICS, INC. |
发明人 |
RIXON, MARK, W.;GROSS, JANE, A. |
| 分类号 |
C12N15/09;A61K38/00;A61K39/395;A61K48/00;A61P35/00;C07K14/705;C07K14/715;C07K16/00;C07K19/00;(IPC1-7):A61K39/395 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
